[SLRX] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
03-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -4.66%
YoY- 13.80%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 283 414 336 243 299 599 113 84.11%
PBT -8,029 -9,332 -8,805 -8,268 -7,900 -10,637 -11,363 -20.61%
Tax -74 0 0 0 -112 0 0 -
NP -8,029 -9,332 -8,805 -8,268 -7,900 -10,637 -11,363 -20.61%
Tax Rate - - - - - - - -
Total Cost 8,312 9,746 9,140 8,511 8,199 11,237 11,476 -19.30%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -2,837.10 -2,256.31 -2,624.15 -3,408.99 -2,642.14 -1,775.66 -10,083.98 -56.96%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -284.43 -335.48 -321.24 -306.27 -297.08 -406.35 -440.98 -25.28%
EPS Diluted -284.43 -335.48 -321.24 -306.27 -297.08 -406.35 -440.98 -25.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.